These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3501992)

  • 1. Fluoxetine-induced weight loss in overweight non-depressed humans.
    Ferguson JM; Feighner JP
    Int J Obes; 1987; 11 Suppl 3():163-70. PubMed ID: 3501992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a serotonin re-uptake inhibitor, fluoxetine, in the treatment of obesity.
    Levine LR; Rosenblatt S; Bosomworth J
    Int J Obes; 1987; 11 Suppl 3():185-90. PubMed ID: 3501994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.
    Byerley WF; Reimherr FW; Wood DR; Grosser BI
    J Clin Psychopharmacol; 1988 Apr; 8(2):112-5. PubMed ID: 3286684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction.
    Goldstein DJ; Rampey AH; Potvin JH; Masica DN; Beasley CM
    J Clin Psychiatry; 1993 Aug; 54(8):309-16. PubMed ID: 8253699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder.
    Chouinard G
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):32-7. PubMed ID: 3882679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine for depression.
    Med Lett Drugs Ther; 1988 Apr; 30(764):45-7. PubMed ID: 3258399
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluoxetine-induced weight loss in overweight, nondepressed subjects.
    Ferguson JM
    Am J Psychiatry; 1986 Nov; 143(11):1496. PubMed ID: 3535547
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose fluoxetine therapy for depression.
    Wernicke JF; Dunlop SR; Dornseif BE; Bosomworth JC; Humbert M
    Psychopharmacol Bull; 1988; 24(1):183-8. PubMed ID: 3290940
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind treatment of major depression with fluoxetine: use of pattern analysis and relation of HAM-D score to CGI change.
    Goodnick PJ; Fieve RR; Peselow ED; Barouche F; Schlegel A
    Psychopharmacol Bull; 1987; 23(1):162-3. PubMed ID: 3496624
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluoxetine in family practice patients.
    Taylor AT; Wagner PJ; Pritchard DC; Tollison JW
    J Fam Pract; 1994 Jul; 39(1):45-9. PubMed ID: 8027732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern analysis of antidepressant response to fluoxetine.
    Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
    J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose fluoxetine therapy for depression.
    Wernicke JF; Dunlop SR; Dornseif BE; Zerbe RL
    Psychopharmacol Bull; 1987; 23(1):164-8. PubMed ID: 3496625
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.
    Feighner JP; Cohn JB
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):20-5. PubMed ID: 3882676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub).
    Levine LR; Enas GG; Thompson WL; Byyny RL; Dauer AD; Kirby RW; Kreindler TG; Levy B; Lucas CP; McIlwain HH
    Int J Obes; 1989; 13(5):635-45. PubMed ID: 2583918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.
    Dastjerdi MS; Kazemi F; Najafian A; Mohammady M; Aminorroaya A; Amini M
    Int J Obes (Lond); 2007 Apr; 31(4):713-7. PubMed ID: 16969361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
    Cohn JB; Wilcox C
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.